95 results
Page 2 of 5
NT 10-K
w91ay649luw2q chm452
31 Mar 23
Notice of late annual filing
4:05pm
8-K
EX-99.1
jvi3xk9001p3nq aaa5
16 Aug 22
Qualigen Therapeutics, Inc. Reports Second Quarter 2022 Financial Results and Provides Corporate Update
6:20am
8-K
EX-99.1
wngeu8dbna7lz s2k2vw
2 Jun 22
Qualigen Therapeutics Acquires Majority Stake in Infectious
9:10am
8-K
EX-99.1
vbrxk
13 May 22
Qualigen Therapeutics, Inc. Provides Corporate Update
6:05am
8-K
EX-99.1
ewiytf
4 May 22
Qualigen Therapeutics to Acquire Majority Stake in Diagnostics Technology Company NanoSynex
4:06pm
8-K
l4pav2kbupb2
10 Dec 21
Entry into a Material Definitive Agreement
1:09pm
8-K
EX-99.1
jo5z2
1 Dec 21
Qualigen Therapeutics, Inc. Announces Closing of $8.82 Million Registered Direct Offering
3:39pm
424B5
4lmr4ow6yagkjag2o
1 Dec 21
Prospectus supplement for primary offering
2:28pm